Evaluation of Drug-Polymer and Drug-Drug Interaction in Cellulosic Multi-Drug Delivery Matrices.

IF 2.3 Q3 BIOCHEMICAL RESEARCH METHODS
Abdullah Isreb, Mohamed A Alhnan, Abdulrahman Mkia, Khaled Al-Jammal, Abdallah M Yaghi, Enoche Florence Oga, Peter Timmins, Michael Bonner, Robert T Forbes
{"title":"Evaluation of Drug-Polymer and Drug-Drug Interaction in Cellulosic Multi-Drug Delivery Matrices.","authors":"Abdullah Isreb, Mohamed A Alhnan, Abdulrahman Mkia, Khaled Al-Jammal, Abdallah M Yaghi, Enoche Florence Oga, Peter Timmins, Michael Bonner, Robert T Forbes","doi":"10.3390/mps8010004","DOIUrl":null,"url":null,"abstract":"<p><p>Multi-drug delivery systems have gained increasing interest from the pharmaceutical industry. Alongside this is the interest in amorphous solid dispersions as an approach to achieve effective oral delivery of compounds with solubility-limited bioavailability. Despite this, there is limited information regarding predicting the behavior of two or more drugs (in amorphous forms) in a polymeric carrier and whether molecular interactions between the compounds, between each compound, and if the polymer have any effect on the physical properties of the system. This work studies the interaction between model drug combinations (two of ibuprofen, malonic acid, flurbiprofen, or naproxen) dispersed in a polymeric matrix of hypromellose acetate succinate (HPMCAS) using a solvent evaporation technique. Hildebrand and Hansen calculations were used to predict the miscibility of compounds as long as the difference in their solubility parameter values was not greater than 7 MPa<sup>1/2</sup>. It was observed that the selected APIs (malonic acid, ibuprofen, naproxen, and flurbiprofen) were miscible within the formed polymeric matrix. Adding the API caused depression in the Tg of the polymer to certain concentrations (17%, 23%, 13%) for polymeric matrices loaded with malonic acid, ibuprofen, and naproxen, respectively. Above this, large crystals started to form, and phase separation was seen. Adding two APIs to the same matrix resulted in reducing the saturation concentration of one of the APIs. A trend was observed and linked to Hildebrand and Hansen solubility parameters (HSP).</p>","PeriodicalId":18715,"journal":{"name":"Methods and Protocols","volume":"8 1","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755489/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Methods and Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/mps8010004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Multi-drug delivery systems have gained increasing interest from the pharmaceutical industry. Alongside this is the interest in amorphous solid dispersions as an approach to achieve effective oral delivery of compounds with solubility-limited bioavailability. Despite this, there is limited information regarding predicting the behavior of two or more drugs (in amorphous forms) in a polymeric carrier and whether molecular interactions between the compounds, between each compound, and if the polymer have any effect on the physical properties of the system. This work studies the interaction between model drug combinations (two of ibuprofen, malonic acid, flurbiprofen, or naproxen) dispersed in a polymeric matrix of hypromellose acetate succinate (HPMCAS) using a solvent evaporation technique. Hildebrand and Hansen calculations were used to predict the miscibility of compounds as long as the difference in their solubility parameter values was not greater than 7 MPa1/2. It was observed that the selected APIs (malonic acid, ibuprofen, naproxen, and flurbiprofen) were miscible within the formed polymeric matrix. Adding the API caused depression in the Tg of the polymer to certain concentrations (17%, 23%, 13%) for polymeric matrices loaded with malonic acid, ibuprofen, and naproxen, respectively. Above this, large crystals started to form, and phase separation was seen. Adding two APIs to the same matrix resulted in reducing the saturation concentration of one of the APIs. A trend was observed and linked to Hildebrand and Hansen solubility parameters (HSP).

纤维素多药传递基质中药物-聚合物和药物-药物相互作用的评价。
多药给药系统已引起制药行业越来越多的兴趣。除此之外,无定形固体分散体作为一种实现有效口服递送具有溶解度限制的生物利用度化合物的方法也引起了人们的兴趣。尽管如此,关于预测两种或两种以上药物(以无定形形式)在聚合物载体中的行为以及化合物之间、每种化合物之间的分子相互作用以及聚合物是否对系统的物理性质有任何影响的信息有限。本研究使用溶剂蒸发技术研究了分散在丙烯酸羟丙甲糖聚合物基质中的模型药物组合(布洛芬、丙二酸、氟比洛芬和萘普生)之间的相互作用。只要溶解度参数值的差值不大于7 MPa1/2,就可以用Hildebrand和Hansen计算来预测化合物的混相性。观察到所选择的原料药(丙二酸、布洛芬、萘普生和氟比洛芬)在形成的聚合物基质内可混溶。添加API后,对于负载丙二酸、布洛芬和萘普生的聚合物基质,其Tg分别在一定浓度(17%、23%和13%)下下降。在此之上,大晶体开始形成,并且可以看到相分离。在同一基质中加入两种原料药会降低其中一种原料药的饱和浓度。观察到一种趋势,并将其与Hildebrand和Hansen溶解度参数(HSP)联系起来。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Methods and Protocols
Methods and Protocols Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (miscellaneous)
CiteScore
3.60
自引率
0.00%
发文量
85
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信